Six-year prognosis of diabetic patients with coronary artery disease

European Journal of Clinical Investigation

Volumn 42, Issue 4, 2012, Pages 376-383

  Nodari, Savina ^a   Manerba, Alessandra ^a   Vaccari, Alberto ^a   Milesi, Giuseppe ^a   Carubelli, Valentina ^a   Lazzarini, Valentina ^a   Lombardi, Carlo ^a   Ettori, Federica ^a   Metra, Marco ^a   Dei Cas, Alessandra ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Coronary angiography; Coronary artery disease; Hyperglycaemia; Type 2 diabetes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NITRATE; ORAL ANTIDIABETIC AGENT; POTASSIUM; SODIUM; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; SODIUM BLOOD LEVEL; TRANSTHORACIC ECHOCARDIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84858290167     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02593.x     Document Type: Article

References (44)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. International Diabetes Federation. International Diabetes Federation Task Force on Diabetes Health Economics: Facts, Figures and Forecasts. Brussels: International Diabetes Federation; 1997: Vol 22: pp 131-48.
3. Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey. Diabetes Care 1991;14:537-43.
4. Miettinen H, Lehto S, Salomaa V, Mähönen M, Niemelä M, Haffner SM et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69-75.
5. Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Rydén L et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004;43:585-91.
6. Bell DS. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 1995;18:708-14.
7. Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak TA et al. Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation 2000;101:2682-9.
8. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136.
9. Ng VG, Lansky AJ. Novel QCA methodologies and angiographic scores. Int J Cardiovasc Imaging 2011;27:157-65.
10. Akhter J. The American Diabetes Association's Clinical Practice Recommendations and the developing world. Diabetes Care 1997;20:1044-5.
11. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
13. Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, Scholte Op Reimer W et al. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 2006;27:2969-74.
14. Anselmino M, Ohrvik J, Rydén L; on behalf of the Euro Heart Survey Investigators. Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the Euro Heart Survey on Diabetes and the Heart. Eur Heart J 2010;31:3040-5.
15. BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.
16. Lee TT, Feinberg L, Baim DS, Holmes DR, Aroesty JM, Carrozza JP Jr et al. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials). Am J Cardiol 2006;98:718-21.
17. Yan RT, Yan AT, Tan M, McGuire DK, Leiter L, Fitchett DH et al. Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes. Am Heart J 2006;152:676-83.
18. Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders LD et al. Long-term survival in 11, 661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Am Heart J 2001;142:119-26.
19. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 2009;122:152-61.
20. Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 2010;55:1067-75.
21. Lee MS, Yang T, Dhoot J, Iqbal Z, Liao H. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease. Am J Cardiol 2010;105:1540-4.
22. Berger JS, Sanborn TA, Sherman W, Brown DL. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention. Am Heart J 2006;151:1026-31.
23. Onuma Y, Kukreja N, Daemen J. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv 2009;2:603-10.
24. Singh M, Rihal CS, Gersh BJ, Roger VL, Bell MR, Lennon RJ et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol 2008;51:2313-20.
25. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
26. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000;36:679-84.
27. Nag S, Bilous R, Kelly W, Jones S, Roper N, Connolly V. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10years' data from the South Tees Diabetes Mortality study. Diabet Med 2007;24:10-7.
28. Knobler H, Zornitzki T, Vered S, Oettinger M, Levy R, Caspi A et al. Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria. J Am Coll Cardiol 2004;44:2142-8.
29. Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M et al. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol 2009;104:1647-53.
30. Maluenda G, Delhaye C, Gaglia MA Jr, Ben-Dor I, Gonzalez MA, Hanna NN et al. A novel percutaneous coronary intervention risk score to predict one-year mortality. Am J Cardiol 2010;106:641-5.
31. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant 2002;17(Suppl 11):50-4.
32. McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol 2003;41:725-8.
33. Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 2007;99:879-84.
34. Jeremias A, Gruberg L, Patel J, Connors G, Brown DL. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2010;105:1268-71.
35. Cohen-Solal A, Beauvais F, Logeart D. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Card Fail 2008;14:615-25.
36. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J 2008;29:1377-85.
37. Lewis EF, Solomon SD, Jablonski KA, Rice MM, Clemenza F, Hsia J et al. Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. Circ Heart Fail 2009;2:209-16.
38. Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC et al. Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients. Eur Heart J 2010;31:1583-90.
39. Lemesle G, Bonello L, de Labriolle A, Maluenda G, Syed AI, Collins SD et al. Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation. Am J Cardiol 2009;104:41-5.
40. Issa VS, Amaral AF, Cruz FD, Ayub-Ferreira SM, Guimarães GV, Chizzola PR et al. Glycemia and prognosis of patients with chronic heart failure - subanalysis of the Long-term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients (REMADHE) trial. Am Heart J 2010;159:90-7.
41. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486-502.
42. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
43. van Gaal WJ, Ponnuthurai FA, Selvanayagam J, Testa L, Porto I, Neubauer S et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 2009;135:60-5.
44. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007;99:1072-81.